Teleflex stock: buy or sell?
August 22nd, 2019
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
Should I buy Teleflex stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best time to buy them. At Stocks2.com, we use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best.
Currently, 2 buy setups work for Teleflex stock now:
|New all-time high||Yes|
|New 52 week high||Yes|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Teleflex stock a buy?
Banks and financial institutions publish stock ratings everyday.At Stocks2.com, we gathered 15 ratings published for TFX stock in the last 30 days. The general sentiment of these ratings is bullish for TFX stock, with 9 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-2||Needham & Company LLC||Buy||Buy|
|2019-8-2||Needham & Company LLC||Buy||Buy|
|2019-6-11||Wells Fargo & Co||n/a||Outperform|
|2019-4-15||Barclays||Equal Weight||Equal Weight|
|2019-3-26||Needham & Company LLC||n/a||Buy|
|2019-2-22||Needham & Company LLC||Strong-Buy||Strong-Buy|
|2019-2-22||Needham & Company LLC||n/a||Strong-Buy|
Teleflex stock analysis
Teleflex decreased -0.44% to $366.16 after topping to all time highs on August 20th.
After topping to all time highs on August/20, Teleflex decreased -0.44% today to $366.16. On April TFX price bounced up over the SMA of 100 days demonstrating to be a significant support for this stock. On Aug 20th, TFX hit a new all time high, pushing higher than on Monday tops. Check different trading setups that use ATHs as triggers.
Teleflex topped new all time highs again this week, marking to $373.90. Shares ended at $366.16 and depreciated -0.99% during the week.
Teleflex stock is drawing an uptrend with rising tops and bottoms. Now trading in between its last bottom and last top, TFX might consolidate in a flat-base, waiting to break out over or down under . Since early March when SMA20w and SMA40w crossed up, TFX price gained $72.26 per share (24.59%). Since price and SMA40w lines crossed up late January, TFX climbed $109.08 (42.43%).
Teleflex stock price history
Teleflex IPO was on March 17th, 1980 at $0.73 per share1. Since then, TFX stock surged a 50,058.90%, with an average of 1,283.60% per year. If you had invested right after TFX's IPO a $1,000 in Teleflex stock in 1980, it would worth $500,589.00 today.
1: Adjusted price after possible price splits or reverse-splits.
Teleflex stock historical price chart
TFX stock reached all-time highs on Aug 20th with a price of $373.90.
Teleflex stock price target is $356.40Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. For the last month we found 15 price forecasts for Teleflex stock:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-5||JMP Securities||Raises Target||$325.00||$395.00||21.5%|
|2019-8-2||Raymond James||Raises Target||$350.00||$420.00||20%|
|2019-8-2||Needham & Company LLC||Reiterates||$325.00||$403.00||24%|
|2019-8-2||Needham & Company LLC||Raises Target||$325.00||$403.00||24%|
|2019-8-2||Morgan Stanley||Raises Target||$345.00||$392.00||13.6%|
|2019-7-16||Morgan Stanley||Raises Target||$320.00||$345.00||7.8%|
|2019-6-11||Wells Fargo & Co||Initiates||n/a||$345.00||-|
|2019-3-27||Raymond James||Raises Target||$320.00||$348.00||8.8%|
|2019-3-26||Needham & Company LLC||Reiterates||n/a||$325.00||-|
|2019-3-22||UBS Group||Raises Target||n/a||$350.00||-|
|2019-2-22||Needham & Company LLC||Reiterates||$300.00||$325.00||8.3%|
|2019-2-22||Needham & Company LLC||Raises Target||$300.00||$325.00||8.3%|
Financials and fundamental analysis
Earnings date and Earnings per ShareAfter publishing its last earnings report on February, Teleflex . Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsCompared to 2017, last anual sales report draw an astounding gain of 14.07% to $2,448.38 M USD. When comparing 2018 vs 2017, in contrast, profit margin (that is, the net income divided by revenues) raised a 1.09% to 8.20%.
|2013||$1,700 M||-||$151 M8.9%||-|
|2014||$1,840 M||8.23%||$188 M10.2%||24.03%|
|2015||$1,810 M||-1.64%||$245 M13.5%||30.47%|
|2016||$1,868 M||3.22%||$237 M12.7%||-3.06%|
|2017||$2,146 M||14.90%||$153 M7.1%||-35.74%|
|2018||$2,448 M||14.07%||$201 M8.2%||31.65%|
Quarterly financial resultsTeleflex posted $641.62 million in sales for 2018-Q4, a 5.24% up compared to previous quarter. Reported quarter earnings marked $90.59 M with a profit margin of 14.12%. Profit margin gained a 4.85% compared to previous quarter when profit margin was 9.27%. When comparing turnover to same quarter last year, Teleflex sales marked a pretty good increase and rose a 7.82%.
|2017-Q2||$529 M||-||$78 M14.8%||-|
|2017-Q3||$535 M||1.15%||$77 M14.4%||-1.72%|
|2017-Q4||$595 M||11.30%||$-43 M-7.2%||-155.39%|
|2018-Q1||$587 M||-1.32%||$56 M9.6%||-231.71%|
|2018-Q2||$610 M||3.85%||$-2 M-0.4%||-104.44%|
|2018-Q3||$610 M||-0.03%||$57 M9.3%||-2,364.58%|
|2018-Q4||$642 M||5.24%||$91 M14.1%||60.27%|
|2019-Q1||$614 M||-4.37%||$41 M6.7%||-54.85%|
Teleflex ownershipWhen you are planning to buy a company, it's worth to review its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Teleflex, 0.25% of all outstanding shares are owned by its staff.
Bearish positions for TFX stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Teleflex:
|Market cap||$16.9 B||$8.8 B||$706.8 M||$68.8 B||$59.3 B|
|Total shares||46.2 M||45.3 M||37.3 M||269.7 M||1,390.0 M|
|Float shares||46.0 M||44.4 M||36.8 M||269.1 M||1,390.0 M|
|- Institutional holdings (%)||95.2%||89.8%||102.5%||87.5%||93.4%|
|- Insider holdings (%)||0.2%||4.1%||2.5%||0.3%||0.2%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Thursday, August 22nd, 2019|
|Day range||$361.99 - $369.37|
|Average true range||$8.16|
|50d mov avg||$344.50|
|100d mov avg||$319.60|
|200d mov avg||$294.60|
Teleflex performancePerformance as an absolute value is never valid if it's not benchmarked against competitors or related stocks in the industry. For Teleflex, the benchmark is made against ABIOMED, AngioDynamics, Becton, Dickinson and, Boston Scientific, The Cooper Companies, General Electric, Integra LifeSciences, and Merit Medical Systems.
|COOThe Cooper Compan...||13.27%||12.74%||26.89%|
|MMSIMerit Medical Sys...||-34.37%||-41.91%||-39.95%|
Teleflex competitorsOne check before investing in any stock is to have a look a list of its competitors, in this case for Teleflex. We picked 9 companies as Teleflex competitors as they are in the same industry or have similar market objectives.
- ABIOMED (ABMD)
- AngioDynamics (ANGO)
- Becton, Dickinson and (BDX)
- Boston Scientific (BSX)
- The Cooper Companies (COO)
- General Electric (GE)
- Integra LifeSciences (IART)
- Merit Medical Systems (MMSI)
Latest Teleflex stock news
- InvestorPlaceHere’s Why Markets Are Willing To Value Teleflex Stock At A PremiumJanuary 21, 2019
- Seeking AlphaTeleflex: Acceleration In 2H18 And 2019 Provides An Attractive Set-Up For A Slow-Growth EnvironmentOctober 31, 2018
- InvestorPlace5 Things to Know About Teleflex StockSeptember 19, 2018